Furong Shu

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Shihui Chen, Xiaolan Zhao, Li Ran et al. · Digestive and Liver Disease · 2014 · 308 citations

Obesity, Metabolic Syndrome, Insulin Resistance +10

Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial

Shihui Chen, Xiaolan Zhao, Jing Wan et al. · Pharmacological Research · 2015 · 232 citations

Obesity, Metabolic Syndrome, Hepatology +11

Ampelopsin Induces Cell Growth Inhibition and Apoptosis in Breast Cancer Cells through ROS Generation and Endoplasmic Reticulum Stress Pathway

Yong Zhou, Furong Shu, Xinyu Liang et al. · PLoS ONE · 2014 · 107 citations · Full text

Ros Generation, Chemoprevention Strategy, Apoptosis +22

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial

Yu Qin, Yong Zhou, Shihui Chen et al. · PLoS ONE · 2015 · 99 citations · Full text

Ampelopsin‐induced autophagy protects breast cancer cells from apoptosis through <scp>A</scp>kt‐m<scp>TOR</scp> pathway via endoplasmic reticulum stress

Yong Zhou, Xinyu Liang, Hui Chang et al. · Cancer Science · 2014 · 70 citations · Full text

Ampelopsin‐induced Autophagy Protects, Mitophagy, Apoptosis +19